CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Biocept Inc  (BIOC)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
 
 

BIOC's Revenue Year on Year Growth by Quarter and Year

Biocept Inc's Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
BIOC Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 1.29 - 0.08
III Quarter September - 1.05 0.16 0.01
II Quarter June 1.28 0.66 0.08 0.02
I Quarter March 1.68 0.22 0.15 0.03
FY   2.96 3.22 0.39 0.14

Financial Statements
Biocept Inc's second quarter 2017 Revenue $ 1.28 millions BIOC's Income Statement
Biocept Inc's second quarter 2016 Revenue $ 0.66 millions Quarterly BIOC's Income Statement
BIOC's Growth by Division See BIOC's Growth by Segment

BIOC Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - - - -99.71 %
III Quarter September - 556.25 % 1500 % -99.96 %
II Quarter June 93.78 % 725 % 300 % -99.91 %
I Quarter March 663.64 % 46.67 % 400 % -99.87 %
FY   - 725.64 % 178.57 % -



BIOC Revenue Growth Comment
Biocept Inc reported Revenue rise of 93.78% year on year in the second quarter, to $ 1.28 millions, this is lower than Biocept Inc's recent average Revenue surge of 470.39%.

Looking into second quarter results within Medical Laboratories industry 5 other companies have achieved higher Revenue growth. While Biocept Inc' s Revenue jump of 93.78% ranks overall at the positon no. 249 in the second quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #6
Healthcare Sector #58
Overall #249
Revenue Y/Y Growth Statistics
High Average Low
1504.59 % 470.39 % -100 %
(Sep 30 2015)   (Dec 31 2015)

You need to upgrade your Flash Player

Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BIOC's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for BIOC's Competitors
Revenue Growth for Biocept Inc's Suppliers
Revenue Growth for BIOC's Customers

You may also want to know
BIOC's Annual Growth Rates BIOC's Profitability Ratios BIOC's Asset Turnover Ratio BIOC's Dividend Growth
BIOC's Roe BIOC's Valuation Ratios BIOC's Financial Strength Ratios BIOC's Dividend Payout Ratio
BIOC's Roa BIOC's Inventory Turnover Ratio BIOC's Growth Rates BIOC's Dividend Comparisons



Companies with similar Revenue jump for the quarter ending Jun 30 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2017
Invitae Corp  156.87 %$ 156.872 millions
Biolargo, Inc.  156.45 %$ 156.446 millions
Lifestyle Medical Network, Inc.  153.16 %$ 153.158 millions
Rewalk Robotics Ltd.  145.65 %$ 145.655 millions
Viewray, Inc.  133.44 %$ 133.445 millions
Psivida Corp.  130.59 %$ 130.592 millions
Second Sight Medical Products Inc  115.62 %$ 115.622 millions
American Cannabis Company, Inc.  114.76 %$ 114.760 millions
Novocure Ltd  114.16 %$ 114.164 millions
Geovax Labs, Inc.  111.77 %$ 111.774 millions
Kite Pharma, Inc.  109.64 %$ 109.635 millions
U.s. Stem Cell, Inc.  104.34 %$ 104.345 millions
Innovus Pharmaceuticals, Inc.  99.96 %$ 99.962 millions
Adamis Pharmaceuticals Corp  97.36 %$ 97.363 millions
Biocept Inc  92.95 %$ 92.946 millions
Dimension Therapeutics, Inc.  84.27 %$ 84.268 millions
Egalet Corp  81.30 %$ 81.304 millions
Dariohealth Corp.  80.87 %$ 80.867 millions
Innoviva, Inc.  80.35 %$ 80.346 millions
Corcept Therapeutics Inc  80.28 %$ 80.283 millions
Mri Interventions, Inc.  79.01 %$ 79.005 millions
Anavex Life Sciences Corp.  77.18 %$ 77.175 millions
China Yct International Group, Inc.  76.42 %$ 76.421 millions
Pieris Pharmaceuticals, Inc.  72.70 %$ 72.702 millions
Omeros Corp  71.44 %$ 71.441 millions
Nephros Inc  68.76 %$ 68.762 millions
Teladoc, Inc.  68.34 %$ 68.344 millions
Intelgenx Technologies Corp.  67.56 %$ 67.560 millions
Keryx Biopharmaceuticals Inc  63.05 %$ 63.049 millions
Neurometrix, Inc.  62.80 %$ 62.802 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SOYL's Profile

Stock Price

SOYL's Financials

SOYL's Expectations

Business Description

Fundamentals

Charts & Quotes

SOYL's News

Suppliers

SOYL's Competitors

Customers & Markets

Economic Indicators

SOYL's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com